Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

The use of DDAVP in children with bleeding disorders.

Ben-Ami T, Revel-Vilk S.

Pediatr Blood Cancer. 2013;60 Suppl 1:S41-3. doi: 10.1002/pbc.24335. Epub 2012 Oct 25. Review.

PMID:
23109357
2.

Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders.

Nolan B, White B, Smith J, O'Reily C, Fitzpatrick B, Smith OP.

Br J Haematol. 2000 Jun;109(4):865-9.

PMID:
10929043
3.

Assessment and validation of a defined fluid restriction protocol in the use of subcutaneous desmopressin for children with inherited bleeding disorders.

Mason JA, Robertson JD, McCosker J, Williams BA, Brown SA.

Haemophilia. 2016 Sep;22(5):700-5. doi: 10.1111/hae.12949. Epub 2016 Jul 6.

PMID:
27385253
4.

Desmopressin (DDAVP) responsiveness in children with von Willebrand disease.

Revel-Vilk S, Schmugge M, Carcao MD, Blanchette P, Rand ML, Blanchette VS.

J Pediatr Hematol Oncol. 2003 Nov;25(11):874-9.

PMID:
14608197
5.

Response of patients with hemophilia A and von Willebrand disease to desmopressin (DDAVP).

Santiago-Borrero PJ, Casanova R.

Bol Asoc Med P R. 1990 May;82(5):207-10.

PMID:
2115785
6.

Response of patients with bleeding disorder to DDAVP administration.

Chuansumrit A, Hathirat P, Pintadit P, Isarangkura P.

Southeast Asian J Trop Med Public Health. 1993;24 Suppl 1:174-9.

PMID:
7886567
7.
8.

Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.

Hanebutt FL, Rolf N, Loesel A, Kuhlisch E, Siegert G, Knoefler R.

Haemophilia. 2008 May;14(3):524-30. doi: 10.1111/j.1365-2516.2008.01672.x. Epub 2008 Feb 18.

PMID:
18284449
9.

Intraleucocyte platelet-activating factor levels in desmopressin-treated patients with haemophilia A and von Willebrand disease.

Kavakli K, Hüseyinov A, Coker I, Aydinok Y, Nisli G.

Haemophilia. 2001 Sep;7(5):482-9.

PMID:
11554936
10.

DDAVP in acquired von Willebrand syndrome associated with multiple myeloma.

Takahashi H, Nagayama R, Tanabe Y, Satoh K, Hanano M, Mito M, Shibata A.

Am J Hematol. 1986 Aug;22(4):421-9.

PMID:
3088986
11.
12.

The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977-2007).

Federici AB.

Haemophilia. 2008 Jan;14 Suppl 1:5-14. doi: 10.1111/j.1365-2516.2007.01610.x. Review.

PMID:
18173689
13.

Desmopressin (DDAVP) for treatment of disorders of hemostasis.

Mannucci PM.

Prog Hemost Thromb. 1986;8:19-45. Review.

PMID:
3104987
14.

DDAVP--the multipotent drug in patients with coagulopathies.

Schulman S.

Transfus Med Rev. 1991 Apr;5(2):132-44. Review. No abstract available.

PMID:
1821643
15.

[Treatment of hemophilia A and von Willebrand's disease with 1-deamino-8-D-arginine vasopressin (DDAVP). Hemophilia and DDAVP].

Ingerslev J, Christiansen SE, Kristensen T, Wallevik K, Bernvil SS.

Ugeskr Laeger. 1985 Nov 4;147(45):3592-4. Danish. No abstract available.

PMID:
3907076
16.

Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.

Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U.

Clin Appl Thromb Hemost. 2007 Jan;13(1):14-34. Review.

PMID:
17164493
17.

The clinical significance of different routes of desmopressin (DDAVP) administration in various bleeding disorders.

Mörsdorf S, Köhler M, Leipnitz G, Wenzel E.

Folia Haematol Int Mag Klin Morphol Blutforsch. 1988;115(4):503-7.

PMID:
2465962
18.
19.

Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease.

Rose EH, Aledort LM.

Ann Intern Med. 1991 Apr 1;114(7):563-8.

PMID:
1900403
20.

Response to desmopressin of factors XI, X and V in patients with factor VIII deficiency and von Willebrand disease.

White B, Lawler P, Riddell A, Nitu-Whalley IC, Hermans C, Lee CA, Brown SA.

Br J Haematol. 2004 Jul;126(1):100-4.

PMID:
15198739

Supplemental Content

Support Center